Zur Merkliste hinzufügen
Zurück

 

29955-01 - Vorlesung: Immunosafety 1 KP

Semester Frühjahrsemester 2022
Angebotsmuster Jedes Frühjahrsem.
Dozierende Andreas J. Bircher (andreas.bircher@unibas.ch)
Tobias Manigold (tobias.manigold@unibas.ch)
Alex Odermatt (alex.odermatt@unibas.ch, BeurteilerIn)
Thomas Singer (thomas.singer@unibas.ch)
Daniel Yerly (daniel.yerly@unibas.ch)
Inhalt Principles of the immune system; Immunotoxicology of drugs; Immunosafety of biopharmaceuticals (T. Singer)
Immunosafety risk assessment; Immunosafety toolbox; Risk mitigation strategy (T. Singer)
Principles of T cell stimulation by hapten, prohapten, pi-concept and HLA restricted relations (D. Yerly)
Immune reactions to biologicals: principles and clinic; Drugs and antibody productions: IgE mediated reactons (the penicilin model); anaphylaxis, cross-reactivity, pholcodin model (T. Manigold)
Immun reactions to biologicals: infusion reactions and cytokine release syndromes: risk assessment. Type II and III reactions (haemolytic anaemia, agranulo-cytosis, throbocytopenia, ...) (T. Manigold)
Drugs and the skin: toxicity & contact dermatitis (T. Singer)
Drugs and the skin: cutaneous reactions (MPE, SJS/TEN, AGEP) (A. Bircher)
Risk assessment in drug hypersensitivity - in vivo or in vitro? Is it possible? Examples (M. Kammüller)
Diagnosis of drug hypersensitivity: skin tests, provocation tests, in vitro tests for drug hypersensitivity (A. Bircher)
Examination (T. Singer)
Lernziele The basic principles of immunology should be known by the participants.
Know the principles of immunotoxicological hazard identification and risk assessment of drugs.
Know the basics of drug-induced hypersensitivity.
Understand IgE mediated reactions against drugs.
understand the basics of infusion reactions and cytokine release syndromes.
Know the basics of skin reactions against drugs.
Literatur Peter J. Delves, Seamus J. Martin, Dennis R. Burton, Ivan M. Roitt: Roitt's Essential Immunology; 13th Edition; Wiley-Blackwell; 2017
Bemerkungen Film and sound recordings during the course are strictly forbidden (recorders may be confiscated)
Weblink Department of Pharmaceutical Sciences

 

Teilnahmebedingungen Completed Bachelor degree
Unterrichtssprache Englisch
Einsatz digitaler Medien kein spezifischer Einsatz

 

Intervall Wochentag Zeit Raum
wöchentlich Dienstag 13.15-15.00 Pharmazentrum, Sitzungszimmer 1067
Bemerkungen Seminar room remains reserved for students of this lecture.

Einzeltermine

Datum Zeit Raum
Dienstag 22.02.2022 13.15-15.00 Uhr Pharmazentrum, Findet online statt
Dienstag 01.03.2022 13.15-15.00 Uhr Pharmazentrum, Findet online statt
Dienstag 08.03.2022 13.15-15.00 Uhr Fasnachtsferien
Dienstag 15.03.2022 13.15-15.00 Uhr Pharmazentrum, Findet online statt
Dienstag 22.03.2022 13.15-15.00 Uhr Pharmazentrum, Findet online statt
Dienstag 29.03.2022 13.15-15.00 Uhr Biozentrum, Seminarraum U1.191
Dienstag 05.04.2022 13.15-15.00 Uhr Pharmazentrum, Findet online statt
Module Modul: Translating Pharmacology and Drug Safety to Humans (Masterstudium: Drug Sciences)
Modul: Vertiefung Medizinische Nanowissenschaften (Masterstudium: Nanowissenschaften)
Wahlbereich Master Pharmazie: Empfehlungen (Masterstudium: Pharmazie)
Leistungsüberprüfung Lehrveranst.-begleitend
Hinweise zur Leistungsüberprüfung Please refer to the list:
https://pharma.unibas.ch/en/education/assessments-and-credit-points/continuous-assessments/
An-/Abmeldung zur Leistungsüberprüfung Anm.: Belegen Lehrveranstaltung; Abm.: stornieren
Wiederholungsprüfung keine Wiederholungsprüfung
Skala 1-6 0,5
Wiederholtes Belegen beliebig wiederholbar
Zuständige Fakultät Philosophisch-Naturwissenschaftliche Fakultät, studiendekanat-philnat@unibas.ch
Anbietende Organisationseinheit Departement Pharmazeutische Wissenschaften

Zurück